ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 200

Rheumatic Manifestations and Connective Tissue Diseases in Autoimmune Hepatitis of the Child and the Adult

Federico Zazzetti1, Nora C. Fernandez2, Javier Benavidez2, Luis A. Colombato3, Graciela R. Rodriguez4, Graciela Nardi5, Carolina Bru Morón6, Oscar L. Rillo7, Nelo A. Quadrini8, Stella M. Garay9, Mariana Fabi9, Teresita Gonzalez10 and Juan C. Barreira11, 1Rheumatology, Buenos Aires Hospital Britanico, Buenos Aires, Argentina, 2Hepatology, Buenos Aires British Hospital, Buenos Aires, Argentina, 3Gastroenterology, Buenos Aires British Hospital, Buenos Aires, Argentina, 4Rheumatology, Hospital Dr. Ignacio Pirovano, Buenos Aires, Argentina, 5Gastroenterology, Hospital Dr. Ignacio Pirovano, Buenos Aires, Argentina, 6Rheumatology, Hospital Dr. Enrique Tornú, Buenos Aires, Argentina, 7Rheumatology, Hospital General de Agudos "Dr. E. Tornú", Buenos Aires, Argentina, 8Gastroenterology, Hospital Dr. Enrique Tornú, Buenos Aires, Argentina, 9Rheumatology, Hospital IAEP Sor María Ludovica, La Plata, Argentina, 10Hepatology, Hospital IAEP Sor María Ludovica, La Plata, Argentina, 11Rheumatology, Buenos Aires British Hospital, Buenos Aires, Argentina

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, connective tissue diseases and hepatic disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases: Periodic Fever Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Autoimmune hepatitis (AIH) is a progressive fibrosing inflammatory disease of the liver of unknown etiology, leading to cirrhosis. Its course is usually fluctuating and its clinical manifestations protean. Forty % of type I AIH and 80% of type II is diagnosed in childhood. Up to 30% of patients with AIH will develop rheumatic manifestations. Moreover, AIH can be associated with various connective tissue diseases (CTD), although there is a lack of studies comparing pediatric and adult populations in this regard. The aim was to analyze the frequency of rheumatic manifestations and CTD in patients with AIH in a pediatric population (≤ 16 years old) compared with adults.

Methods: Patients of any age who fulfilled the 1998 modified diagnostic criteria for AIH of the Autoimmune Hepatitis International Group assisted in Hepatology services of the intervening centers. They were clinically evaluated by a hepatologist and referred to a rheumatologist. Demographic, clinical and serological variables, as well as additional studies and biopsies were recorded. Rheumatic manifestations and CTD were registered and defined according to ACR criteria. Means were reported for numeric variables and percentages for categorical. To compare two groups Mann Whitney and Χ2tests were applied. A 0.05 α-error was chosen.

Results:  Forty-eight patients with AIH were analyzed: 28 adults, 89% female, mean age at inclusion 50 ± 17 years (range=19-75) and age at diagnosis of AIH 41 ± 18 years (range=18.6-70), and 20 pediatric, 75% female, mean age at inclusion 13.8 ± 4 years (range=5-16) and age at diagnosis of AIH 9.7 ± 4 years (range=1.5-16). Sixty-four % (18/28) of adults and 55% (11/20) of pediatric had at least one rheumatic manifestation (p=n/s). There were no differences in the type and frequency of rheumatic manifestations analized in the two age groups, including malar rash, oral ulcers, parotitis, photosensitivity, xerophthalmia, xerostomia, telangiectasias, Raynaud’s, vasculitis, xeroderma, subcutaneous nodules, arthralgia, arthritis, myositis, interstitial lung disease, serositis, citopenias, glomerulonephritis, proteinuria and nervous system involvement. Nine CTD were found, 5 in adults (17.8%, SLE=4, Sjögren=1) and 4 in pediatric patients (20%, SLE=3, JIA = 1). Comparing both groups, the pediatric group had more jaundice (p=0.03), hepatomegaly (p=0.0001), cirrhosis (p=0.03), splenomegaly (p=0.003), anemia (p=0.003 ), ESR (p=0.04), AST (p=0.0006), ALT (p=0.006), FAL (p=0.01), total bilirubin (p=0.003), ANA (p=0.04), ASMA (p=0.0001) and LKM (p=0.03). There were no differences regarding histological findings of liver biopsies. Autoimmune thyroiditis was more frequent in adults 4/28 vs 1/20 (p=0.001). 

Conclusion:  The frequency of rheumatic manifestations and CTD was similar in both groups, but pediatric patients had a more severe hepatic involvement and higher levels of autoantibodies. Regardless of age, 2 of 10 patients with AIH presented an associated CTD, and at least half of them developed rheumatic manifestations. Systemic lupus was the most frequent CTD associated to both groups. The systematic search for defined CTD and/or rheumatic manifestations should be an essential part of the clinical evaluation of AIH.


Disclosure:

F. Zazzetti,
None;

N. C. Fernandez,
None;

J. Benavidez,
None;

L. A. Colombato,
None;

G. R. Rodriguez,
None;

G. Nardi,
None;

C. Bru Morón,
None;

O. L. Rillo,

Pfizer Inc,

2;

N. A. Quadrini,
None;

S. M. Garay,
None;

M. Fabi,
None;

T. Gonzalez,
None;

J. C. Barreira,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatic-manifestations-and-connective-tissue-diseases-in-autoimmune-hepatitis-of-the-child-and-the-adult/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology